Halozyme Therapeutics Inc. (HALO)

$ 71.57
   
  • Change Today:
    $-0.04
  • 52 Week High: $71.78
  • 52 Week Low: $42.57
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 1,404,290
  • Market Cap: $10,400m
  • RiskGrade: 189
  • Beta: 0.14

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,343.05 855.85 613.60¢ 11.7 n/a n/a n/a 0.0%
31-Dec-26 1,600.55 1,034.58 791.50¢ 9.0 0.3 +29% n/a 0.0%
31-Dec-27 1,859.94 1,312.49 965.00¢ 7.4 0.3 +22% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 71.57
Change Today $ -0.04
% Change -0.05 %
52 Week High $71.78
52 Week Low $42.57
Volume 1,404,290
Shares Issued 145.30m
Market Cap $10,400m
Beta 0.14
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 3
Sell 1
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Aug-2025

Time Volume / Share Price
13:51 100 @ $71.57
13:49 125 @ $71.61
13:49 100 @ $71.62
13:49 100 @ $71.62
13:49 100 @ $71.59

Top of Page